496 related articles for article (PubMed ID: 23430956)
1. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J
Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956
[TBL] [Abstract][Full Text] [Related]
2. Autophagy induces transforming growth factor-β-dependent epithelial-mesenchymal transition in hepatocarcinoma cells through cAMP response element binding signalling.
Hu S; Wang L; Zhang X; Wu Y; Yang J; Li J
J Cell Mol Med; 2018 Nov; 22(11):5518-5532. PubMed ID: 30134011
[TBL] [Abstract][Full Text] [Related]
3. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation.
Tong H; Yin H; Hossain MA; Wang Y; Wu F; Dong X; Gao S; Zhan K; He W
J Cell Biochem; 2019 Apr; 120(4):5118-5127. PubMed ID: 30320898
[TBL] [Abstract][Full Text] [Related]
4. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
5. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
6. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
Ru NY; Wu J; Chen ZN; Bian H
Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
8. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
9. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
10. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
Wang H; Zhang Y; Wu Q; Wang YB; Wang W
Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833
[TBL] [Abstract][Full Text] [Related]
11. PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma.
Zhang M; Sui C; Dai B; Shen W; Lu J; Yang J
Oncol Rep; 2017 Jan; 37(1):510-518. PubMed ID: 28004118
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
15. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
[TBL] [Abstract][Full Text] [Related]
16. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.
Liu L; Li N; Zhang Q; Zhou J; Lin L; He X
Oncol Res; 2017 Nov; 25(9):1607-1616. PubMed ID: 28492136
[TBL] [Abstract][Full Text] [Related]
19. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
[TBL] [Abstract][Full Text] [Related]
20. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]